Valsartan Market to grow at a formidable rate Durbbing the Forecast Period
Growing prevalence of
cardiovascular diseases is expected to drive the growth of India valsartan
market.
According
to TechSci Research report, “India Valsartan Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution,
Others), By Distribution Channel (Online v/s Offline), By Application
(Hypertension, Heart Failure, Myocardial Infarction, Others), By End User
(Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, the India valsartan market is expected to grow at a formidable
rate during the forecast period on account of the changing lifestyle patterns,
lack of physical exercises, intake of junk food and improper dietary habits.
This has led to increasing incidences of obesity, diabetes, cardiovascular
diseases, among others. This in turn is expected to positively influence the
market growth over the next few years. Additionally, valsartan is widely used
in the treatment of diabetic neuropathy. This in tun is expected to positively
influence the market growth through FY2026. However, side effects such as
headache, nausea, diarrhea, stomach pain, among others associated with
valsartan can restrict the market growth during the forecast period. Moreover,
severe side effects such as difficulty in breathing or swallowing, unexplained
weight gain, among others can further hamper the market growth over the next
few years.
Browse XX market data Tables and XX
Figures spread through XXX
Pages and an in-depth TOC on" India Valsartan Market "
https://www.techsciresearch.com/report/india-valsartan-market/5155.html
The India valsartan market is segmented based on source, form, distribution
channel, application, end user, company and region. Based on form, the market
can be categorized into tablet, capsule, solution and others. The tablet
segment is expected to dominate the market since it can accommodate a large
amount of API as compared to the other counterparts. While capsule segment is
expected to register the highest growth during the forecast period on account
of the associated benefits such as fast action, tamper resistance, higher rate
of absorption, among others. Based on distribution channel, the market can be
split into online and offline. The offline channel is expected to dominate the
market owing to the consumer preference for buying medicines from a pharmacy or
drug store. The online segment is also expected to register significant growth
over the next few years. This can be ascribed to the emergence of several
online pharmacies, digital platforms and mobile applications and doorstep drug
delivery e-commerce platforms in the country.
Jubilant Pharma Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals
Industries Ltd., Amneal Pharmaceuticals Pvt. Ltd., Torrent Pharmaceutical Ltd.,
Unichem Laboratories Ltd., Novartis India Ltd., Dr. Reddy’s Laboratories Ltd.,
Teva Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals Ltd. and others are
some of the leading players operating in India valsartan market. Companies
operating in the market are using organic strategies such as product launches, portfolio
expansions, customer focus approach, mergers and collaborations to boost their
share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5155
Customers can also
request for 10% free customization on this report.
“India valsartan market is expected to
witness growth during the forecast period on account of the growing incidences
of cardiac arrests, strokes, among others. Additionally, the drug is highly
effective in treating hypertension thereby driving the market growth over the
next few years. Furthermore, supportive government policies and schemes
launched by the government of India such as incentive linked production scheme,
establishment of bulk drug parks, among others.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Valsartan Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution,
Others), By Distribution Channel (Online v/s Offline), By Application
(Hypertension, Heart Failure, Myocardial Infarction, Others), By End User
(Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, has
evaluated the future growth potential of India valsartan market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India valsartan market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]